Evidence map›Paper›PMID 40001563›Full record

ArticleBiomolecules2025

Detection of Possible Resistance Mechanisms in Uropathogenic

Soraya Herrera-Espejo, Alejandro Rubio, Lucía Ceballos-Romero, Jerónimo Pachón, Elisa Cordero, Antonio J Pérez-Pulido, María Eugenia Pachón-Ibáñez

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Soraya Herrera-EspejoClinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.ORCID 0000-0001-8019-0905
Alejandro RubioAndalusian Centre for Developmental Biology (CABD, UPO-CSIC-JA), Faculty of Experimental Sciences (Genetics Area), University Pablo de Olavide, 41013 Seville, Spain.ORCID 0000-0002-6736-6141
Lucía Ceballos-RomeroClinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.
Jerónimo PachónInstitute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.ORCID 0000-0002-8166-5308
Elisa CorderoClinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.ORCID 0000-0001-7766-7266
Antonio J Pérez-PulidoAndalusian Centre for Developmental Biology (CABD, UPO-CSIC-JA), Faculty of Experimental Sciences (Genetics Area), University Pablo de Olavide, 41013 Seville, Spain.ORCID 0000-0003-3343-2822
María Eugenia Pachón-IbáñezClinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.ORCID 0000-0001-7969-8162

Funding

Agencia Estatal de Investigación PID2023-150077OB-I00/AEI/10.13039/501100011033Consejería de Economía, Industria y Competitividad US-1381501Instituto de Salud Carlos III PI17/01405Instituto de Salud Carlos III PI20/01255
6 · The paper itself

Abstract

backgroundUrinary tract infections are a global health concern, with uropathogenic

methodsA cohort UPEC was collected from kidney transplant recipients at the Virgen del Rocío University Hospital, Spain. Minimum inhibitory concentrations were determined for ciprofloxacin and fosfomycin to categorize strains into LLCR and LLFR. Twenty strains were selected for WGS, with genome annotations. Point mutations were identified and analyzed using alignment tools, and protein stability changes were predicted.

resultsLLCR strains exhibited mutations in key quinolone resistance-determining regions of the

conclusionsThis study highlights the complex interplay between chromosomal and plasmid genes in UPEC's resistance to ciprofloxacin and fosfomycin. The findings contribute to understanding low-level resistance mechanisms and may guide the development of novel therapeutic strategies to combat multidrug-resistant strains.

Indexed as

Drug Resistance, BacterialEscherichia coli InfectionsKidney TransplantationUropathogenic Escherichia coliAnti-Bacterial AgentsCiprofloxacinEscherichia coli ProteinsFemaleFosfomycinGenome, BacterialHumansMaleMicrobial Sensitivity TestsMiddle AgedPlasmidsTransplant RecipientsAnti-Bacterial AgentsCiprofloxacinEscherichia coli ProteinsFosfomycinantimicrobial resistanceuropathogenic Escherichia coliwhole-genome sequencing

Identifiers

PMID40001563
PMCPMC11853403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.